<DOC>
	<DOCNO>NCT00131638</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety palifermin ( recombinant human keratinocyte growth factor , rHuKGF ) reduce incidence severe oral mucositis subject locally advanced head neck cancer receive radiotherapy concurrent chemotherapy adjuvant treatment disease .</brief_summary>
	<brief_title>A Study Palifermin Reduction Oral Mucositis Subjects With Advanced Head Neck Cancer</brief_title>
	<detailed_description>This study conduct evaluate efficacy palifermin administer intravenously ( IV ) weekly dos ( minimum 7 weekly dos , RT complete ) reduce incidence severe ( World Health Organization [ WHO ] grade 3 4 ) oral mucositis subject locally advance HNC receive RT concurrent CT ( RT/CT ) adjuvant treatment disease ( postoperative setting ) . This study ass safety tolerability palifermin dose 120 Î¼g/kg IV administer weekly ( minimum 7 weekly dos , RT complete ) subject population . This study also evaluate effect palifermin clinical sequela severe OM ( eg , average subject-reported mouth throat soreness [ MTS ] score ) , RT-induced xerostomia population , well long-term effect palifermin disease outcome survival population .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<criteria>History histologically document squamous cell carcinoma ( AJCC [ American Joint Committee Cancer ] Stage II , III , IVA IVB ) involve either oral cavity , oropharynx , hypopharynx , larynx , post surgical resection ( R0 , R1 ) candidate adjuvant RT/CT Radiation treatment field receive plan dose least 50Gy area oral cavity/oropharynx mucosa visualize Eastern Cooperative Oncology Group ( ECOG ) performance status less equal 2 Functional hematopoietic hepatorenal system Tumors lip , paranasal sinus , salivary gland , unknown primary tumor Metastatic disease ( M1 ) Stage IV C Presence history primary malignancy ( curatively treat situ cervical cancer basal cell carcinoma skin ) History chronic pancreatitis episode acute pancreatitis within last year Prior radiation site disease , prior chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Oncology</keyword>
	<keyword>KGF</keyword>
	<keyword>Palifermin</keyword>
	<keyword>Oral mucositis</keyword>
	<keyword>Clinical Trial</keyword>
	<keyword>Amgen</keyword>
	<keyword>head neck</keyword>
</DOC>